Tacrolimus (FK 506)-induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: Salvage with plasmapheresis and prostacyclin

Haematologica

Volumn 85, Issue 6, 2000, Pages 659-662

  Au, Wing Y ^a   Lie, Albert K W ^a   Lam, Clarence C K ^a   Fan, Sheung Tat ^a   Liu, Chi Leung ^a   Young, Karl ^a   Lo, Chung Mau ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Tacrolimus; TTP

Indexed keywords

AUTOANTIBODY; BLOOD GROUP A ANTIBODY; ILOPROST; LACTATE DEHYDROGENASE; LAMIVUDINE; LUPUS ANTICOAGULANT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; PROSTACYCLIN; TACROLIMUS;

ADULT; ARTICLE; BLOOD COMPONENT THERAPY; BLOOD GROUP ABO INCOMPATIBILITY; CADAVER DONOR; CASE REPORT; CLINICAL FEATURE; COOMBS TEST; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PORTAL VEIN THROMBOSIS; RADIODIAGNOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUPING AND CROSSMATCHING; EPOPROSTENOL; FEMALE; HEPATITIS B; HUMANS; LIVER TRANSPLANTATION; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SALVAGE THERAPY; TACROLIMUS;

EID: 0033947462     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Porta C, Caporali R, Montecucco C. Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects. Haematologica 1999; 84: 260-9.
2. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339:1585-94.
3. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339:1578-84.
4. Nagaya S, Wada H, Oka K, et al. Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C. Am J Hematol 1995; 50: 237-43.
5. Porta C, Danova M, Riccardi A, Bobbio Pallavicini E, Ascari E. Cancer chemotherapy-related thrombotic thrombocytopenic purpura: biological evidence of increased nitric oxide production. Mayo Clin Proc 1999; 74:570-4.
6. Moake JL, Byrnes JJ. Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematol Oncol Clin N 1996; 10:485-97.
7. Singh N, Gayowski T, Marino IR. Hemolytic uremic syndrome in solid-organ transplant recipients. Transplant Int 1996; 9:68-75.
8. Trimarchi HM, Truong LD, Brennan S, Gonzalez JM, Suki WN. FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. Transplantation 1999; 67:539-44.
9. GeorgeJN, Gilcher RO, Smith JW, Chandler L, Duvall D, Ellis C. Thrombotic thrombocytopenic purpurahemolytic uremic syndrome: diagnosis and management. J Clin Apheresis 1998; 13:120-5.
10. Lo CM, Fan ST, Lai CL, et al. Lamivudine prophylaxis in liver transplantation for hepatitis B in Asians. Transplant Proc 1999; 31:535-6.
11. Lo CM, Fan ST, Liu CL, et al. Applicability of living donor liver transplantation to high-urgency patients. Transplantation 1999; 67:73-7.
12. Lo CM, Fan ST, Liu CL, et al. Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong. Transplant Proc 1998; 30:3587-8.
13. Bakshi R, Shaikh ZA, Bates VE, Kinkel PR. Thrombotic thrombocytopenic purpura: brain CT and MRI find-ings in 12 patients. Neurology 1999; 52:1285-8.
14. Mok MY, Tse HF, Lau CS. Pulmonary hypertension secondary to systemic lupus erythematosus: prolonged survival following treatment with intermittent low dose iloprost. Lupus 1999; 8:328-31.
15. Ruggenenti P, Remuzzi G. Pathophysiology and management of thrombotic microangiopathies. J Nephrol 1998; 11:300-10.
16. Sutor GC, Schmidt RE, Albrecht H. Thrombotic microangiopathies and HIV infection: report of two typical cases, features of HUS and TTP, and review of the literature. Infection 1999; 27:12-5.
17. Muszkat M, Shapira MY, Sviri S, Linton DM, Caraco Y. Ticlopidine-induced thrombotic thrombocytopenic purpura. Pharmacotherapy 1998; 18:1352-5.
18. Paquette RL, Tran L, Landaw EM. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant 1998; 22:351-7.
19. Porta C, Bobbio-Pallavicini E, Centurioni R, Caporali R, Montecucco CM. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Italian Cooperative Group for TTP. J Rheumatol 1993; 20: 1625-6.
20. Musio F, Bohen EM, Yuan CM, Welch PG. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 1998; 28:1-19.
21. Asherson RA. The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment. Lupus 1998; 7(Suppl 2):S55-62.
22. Kobayashi M, Wada H, Wakita Y, et al. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura. Thromb Haemost 1995; 73:10-4.
23. Tezcan H, Zimmer W, Fenstermaker R, Herzig GP, Schriber J. Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506. Bone Marrow Transplant 1998; 21:105-9.
24. Holman MJ, Gonwa TA, Cooper B, etal. FK506-associated thrombotic thrombocytopenic purpura. Transplantation 1993; 55:205-6.
25. Mach-Pascual S, Samii K, Beris P. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. Am J Hematol 1996; 52:310-2.
26. Abu Elmagd KM, Bronsther O, Kobayashi M, et al. Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. Transplant Proc 1991; 23:3190-2.
27. Angstadt J, Jarrell B, Maddrey W, et al. Hemolysis in ABO-incompatible liver transplantation. Transplant Proc 1987; 19:4595-7.
28. Bandarenko N, Brecher ME. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apheresis 1998; 13:133-41.
29. Hand JP, Lawlor ER, Yong CK, DavisJH. Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura. BrJ Haematol 1998; 100:597-9.
30. Bobbio-Pallavicini E, Porta C, Tacconi F, et al. Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura. Haematologica 1994; 79:429-37.
31. Sagripanti A, Carpi A, Rosaia B, et al. Iloprost in the treatment of thrombotic microangiopathy: report of thirteen cases. Biomed Pharmacother 1996; 50:350-6.
32. Klupp J, Bechstein WO, Platz KP, et al. Mycophenolate mofetil added to immunosuppression after liver transplantation-first results. Transpl Int 1997; 10:223-8.